Assessing the effect of progressive muscle relaxation on glycosylated hemoglobin and health- related quality of life in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015021821134N1

Enrollment

100

Registered

2015-06-04

Start date

2015-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: In intervention group, patients do progressive muscle relaxation to themselves twice a day for three months. In this method patients continuously contract and then relax their muscles

Rehabilitation

In intervention group, patients do progressive muscle relaxation to themselves twice a day for three months. In this method patients continuously contract and then relax their muscles while they are l

In control group: Routin activities

Eligibility

Sex/Gender

All

Age

35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 35 to 65 years; Literacy; A definitive diagnosis of type 2 diabetes by a physician; Oral anti-diabetic medication for at least 1 year; No risk of cardiovascular disease, thyroid disease, intermittent claudication, cerebrovascular accidents, arthritis, diabetic retinopathy, chronic renal failure, chronic pulmonary disease, diabetic foot, severe vision or hearing impairment; Lack of mental illnesses and psychiatric drugs; The absence of sensory perception and communication problems; The absence of limb movement disorders and muscle injury; Not Hype; Lack of relaxation training Exclusion Criteria: The absence of one of the training sessions for the intervention group; Performance progressive muscle relaxation in the house less than 10 sessions per week (record in the self-report check lists); Drug regime change during the 12-week study (in both control and intervention); The use of other complementary therapies during the study; Lack of learning and skill acquisition procedure; Acute complications of diabetes (such as ketoacidosis and hypoglycemia)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Glycosylated hemoglobin. Timepoint: Before and three months after intervention. Method of measurement: Lab Kit.	—

Secondary

Measure	Time frame
Health- related quality of life. Timepoint: Before and three months after intervention. Method of measurement: Diabetes Quality Of Life (DQOL) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kohandany

School of nursing & midwifery of Iran university

Maryamekohandany@hotmail.com; Kohandani.m@tak.iums.ac.ir+98 21 8888 2886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026